Explore the words cloud of the RESTORE project. It provides you a very rough idea of what is the project "RESTORE" about.
The following table provides information about the project.
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
|Coordinator Country||Germany [DE]|
|Total cost||1˙000˙000 €|
|EC max contribution||1˙000˙000 € (100%)|
1. H2020-EU.1.2.3. (FET Flagships)
|Duration (year-month-day)||from 2019-03-01 to 2020-04-30|
Take a look of project's partnership.
|1||CHARITE - UNIVERSITAETSMEDIZIN BERLIN||DE (BERLIN)||coordinator||105˙000.00|
|2||INNOVATION ACTA S.R.L.||IT (ROMA)||participant||587˙500.00|
|3||CELL THERAPY CATAPULT LIMITED||UK (LONDON)||participant||52˙500.00|
|4||FONDAZIONE TELETHON||IT (ROMA)||participant||52˙500.00|
|5||INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE||FR (PARIS)||participant||52˙500.00|
|6||UNIVERSIDADE DO MINHO||PT (BRAGA)||participant||52˙500.00|
|7||UNIVERSITAT ZURICH||CH (ZURICH)||participant||52˙500.00|
|8||PLURISTEM LTD||IL (HAIFA)||participant||15˙000.00|
|9||TISSUSE GMBH||DE (BERLIN)||participant||15˙000.00|
|10||MILTENYI BIOTEC GMBH||DE (BERGISH GLADBACH)||participant||8˙750.00|
|11||MILTENYI BIOTEC BV & CO KG||DE (BERGISCH GLADBACH)||participant||6˙250.00|
Recently, a new class of “living drugs” has been developed – Advanced Therapies which aim to transform the current focus of “treatment of disease” into one that concentrates on “restoration of health” with promising results in a broad field of Regenerative Medicine, including targeted immune reconstitution for cancer treatment. Advanced Therapies are game changing in Health Care and have a rapidly expanding market size of approximately 12 and 50 bn € expected by 2020 and 2030, respectively. There is great value in European science and technology on Advanced Therapies but Europe has been losing ground because of scattered and underpowered efforts. If Europe wants a leading role in this emerging field in the future, a mission-driven approach is required to make the transforming promise of Advanced Therapies a reality. The development of new Advanced Therapy products and their implementation in clinical practice will enhance the value-based outcome of patients. Measurable by having dozens of premier-league Advanced Therapy Products “discovered & made in Europa” by 2030 and beyond. Bringing affordable, standard-of-care for currently incurable diseases which are accessible for every European citizen who need it to RESTORE Health. We propose a mission-driven programme led by the candidate LSRI RESTORE, aiming to build a coordinated, financially strong European partnership between different areas of interest and cross-sectors involving academia, industry, regulatory authorities, health care, patient organisations, and public society. In order to guarantee a smart start of the LSRI from 2021 onwards, the preparation phase aims to involve the growing RESTORE community even more closely in working groups on identified tasks and to jointly complete the RESTORE agenda for Research & Innovation Actions as well as Coordination & Support Actions. The deliverables of RESTORE will allow Europe to gain a world leading health position within this emerging field.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RESTORE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "RESTORE" are provided by the European Opendata Portal: CORDIS opendata.